Botulinum toxin type A prophylactic treatment for episodic migraine using a modified follow-the-pain treatment paradigm: A randomized, double-blind, placebo controlled, phase II study

被引：0
|
作者：
Aurora, SK
Gawel, M
Brandes, J
Pokta, S
VanDenburgh, AM
机构：
[1] Swedish Pain Ctr, Seattle, WA USA
[2] Sunnybrook Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] Nashville Neurosci Grp PC, Nashville, TN USA
[4] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
HEADACHE | 2005年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：825 / 826
页数：2
相关论文
共 50 条
  • [31] Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials
    Shuhendler, Adam J.
    Lee, Soyoung
    Siu, Michelle
    Ondovcik, Stephanie
    Lam, Kyla
    Alabdullatif, Awatif
    Zhang, Xiaochu
    Machado, Marcio
    Einarson, Thomas R.
    PHARMACOTHERAPY, 2009, 29 (07): : 784 - 791
  • [32] A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines
    Carruthers, JA
    Lowe, NJ
    Menter, MA
    Gibson, J
    Nordquist, M
    Mordaunt, J
    Walker, P
    Eadie, N
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) : 840 - 849
  • [33] Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study
    Schulte-Mattler, WJ
    Krack, P
    PAIN, 2004, 109 (1-2) : 110 - 114
  • [34] A randomized, double-blind, placebo-controlled study of botulinum toxin type a for the treatment of glabellar lines: Determination of optimal dose
    Monheit, Gary
    Carruthers, Alastair
    Brandt, Fredric
    Rand, Rhonda
    DERMATOLOGIC SURGERY, 2007, 33 : S51 - S59
  • [35] Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache:: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study
    Silberstein, SD
    Göbel, H
    Jensen, R
    Elkind, AH
    DeGryse, R
    Walcott, JMCM
    Turkel, C
    CEPHALALGIA, 2006, 26 (07) : 790 - 800
  • [36] Botulinum toxin type a compared with divalproex sodium for the prophylactic treatment of migraine: a 9-month randomized, double-blind trial
    Blumenfeld, A.
    Schim, J.
    CEPHALALGIA, 2006, 26 (11) : 1370 - 1371
  • [37] A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
    Voller, B
    Sycha, T
    Gustorff, B
    Schmetterer, L
    Lehr, S
    Eichler, HG
    Auff, E
    Schnider, P
    NEUROLOGY, 2003, 61 (07) : 940 - 944
  • [38] A double-blind comparison of botulinum toxin type A (BoNTA) and topiramate for the prophylactic treatment of transformed migraine headaches: a pilot study
    Mathew, N. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 328 - 328
  • [39] Treatment of chronic radial epicondylitis with botulinum toxin A - A double-blind, placebo-controlled, randomized multicenter study
    Placzek, Richard
    Drescher, Wolf
    Deuretzbacher, Georg
    Hempfing, Axel
    Meiss, A. Ludwig
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2007, 89A (02): : 255 - 260
  • [40] A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson's disease
    Bruno, V.
    Freitas, M.
    Mancini, D.
    Liu, J.
    Miyasaki, J.
    Fox, S.
    MOVEMENT DISORDERS, 2017, 32
12345